CoChat

A small molecule CRTH2 antagonist inhibits FITC-induced allergic cutaneous inflammation

Open access
Boehme, S. A., Franz-Bacon, K., Chen, E. P., Sasik, R., Sprague, L. J., Ly, T. W., Hardiman, G., Bacon, K. B. · 2009 · International Immunology

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

A FITC-induced allergic contact hypersensitivity model was used to investigate the role that the prostaglandin D(2) receptor-chemoattractant receptor-homologous molecule expressed on T(h)2 cells (CRTH2) plays in modulating cutaneous inflammation. Our results show that inhibition of CRTH2, achieved via administration of a potent, small molecule antagonist, Compound A (Cmpd A), effectively blocked edema formation and greatly reduced the inflammatory infiltrate and skin pathology observed in drug vehicle-treated animals. Gene expression analysis revealed that Cmpd A administration down-regulated the transcription of a wide range of pro-inflammatory mediators. This correlated with decreases in cytokine and chemokine protein levels, notably IL-4, IL-1beta, tumor necrosis factor-alpha, transforming growth factor-beta, GRO-alpha, MIP-2 and thymic stromal lymphopoietin (TSLP) in FITC-challenged ears. The administration of an anti-TSLP-neutralizing antibody was only partially effective in lowering the FITC-induced inflammatory infiltrate and cytokine production compared with the CRTH2 antagonist. Taken together, these data suggest that blockade of CRTH2 inhibits multiple pathways leading to cutaneous inflammation in this model. This suggests that CRTH2 antagonism may be a viable route for therapeutic intervention in allergic skin diseases, such as atopic dermatitis.

Overview

Integrity signals

Registry

Crossref · 10.1093/intimm/dxn127

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 35 references

Cited by

See all 65

Metadata

Authors
Boehme, S. A., Franz-Bacon, K., Chen, E. P., Sasik, R., Sprague, L. J., Ly, T. W., Hardiman, G., & Bacon, K. B.
Affiliations
  • University of California San Diego (US)
  • University of California System (US)
Venue
International Immunology
Published
2008-12-09
Volume
21
Issue
1
Pages
81-93
ISSN
  • 0953-8178 (ISSN-L)
  • 1460-2377
OpenAlex
W2104712354
Cited by
60
References
35
Citations by year
2024: 5 · 2023: 1 · 2022: 1 · 2021: 2 · 2019: 1 · 2018: 3 · 2017: 5 · 2016: 4 · 2014: 2 · 2013: 6 · 2012: 7
FWCI
8.22
Type
journal article
Language
en
Open access
Locations
  • International Immunology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK063491)
Topics
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
  • Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
Keywords
CRTH2, prostaglandin D2 receptor, small molecule antagonists, compound A, contact allergy, skin inflammation, thymic stromal lymphopoietin, cytokines, chemokines, IL-4, atopic dermatitis, anti-inflammatory therapy
MeSH terms
Animals, Cell Line, Female, Humans, Mice, Inbred BALB C, Prostaglandin Antagonists, Receptors, Immunologic, Receptors, Prostaglandin, Prostaglandin D2, Gene Expression, Cytokines, Fluorescein-5-isothiocyanate, Dermatitis, Allergic Contact, Th2 Cells, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A small molecule CRTH2 antagonist inhibits FITC-induced allergic cutaneous inflammation. https://app.cochat.ai/papers/10.1093/intimm/dxn127
The paper
Boehme, S. A., Franz-Bacon, K., Chen, E. P., Sasik, R., Sprague, L. J., Ly, T. W., Hardiman, G., & Bacon, K. B. (2009). A small molecule CRTH2 antagonist inhibits FITC-induced allergic cutaneous inflammation. International Immunology. https://doi.org/10.1093/intimm/dxn127

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.